VEGFA and basal cell carcinoma: In human basal cell carcinoma (BCC), M2 TAMs enhanced the potential of invasion and angiogenesis through a COX-2-dependent pathway, resulting in the elevated release of VEGF-A, bFGF and MMP-9 from BCC cells [52].